ReviewMarine drugs2010
N-acetylglucosamine: production and applications.
Review in Marine drugs, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
111 citing papers in PubMed, 386 citations in OpenAlex.
- Enhancing enzyme activity of heterologously expressed Chit42 inBiotechnology reports (Amsterdam, Netherlands) · 2025Article
- Metabolic engineering of Escherichia coli for N-acetyl glucosamine fermentation.World journal of microbiology & biotechnology · 2025Article
- A Safety Evaluation of N-Acetylglucosamine Produced byBiomolecules · 2025Article
- Usage Frequency and Ecotoxicity of Skin Depigmenting Agents.Pharmaceuticals (Basel, Switzerland) · 2025Article
- JG26 attenuates ADAM17 metalloproteinase-mediated ACE2 receptor processing and SARS-CoV-2 infection in vitro.Pharmacological reports : PR · 2025Article
- Recent Advances in Multifaceted Drug Delivery Using Natural Polysaccharides and Polyacrylamide-based Nanomaterials in Nanoformulation.Current topics in medicinal chemistry · 2025Review
- Identification of metabolic pathways modulated by GAM and NGAM in the inhibition ofFrontiers in microbiology · 2025Article
- Targeted urinary metabolomics combined with machine learning to identify biomarkers related to central carbon metabolism for IBD.Frontiers in molecular biosciences · 2025Article
- Recent advancement of glucosamine and N-acetyl glucosamine production using microorganisms: A review.Journal of industrial microbiology & biotechnology · 2024Review
- Modulation of Plet1 expression by N-Acetylglucosamine through the IL-17 A-MAPK pathway in an imiquimod-induced psoriasis mouse model.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024Article
- Exploring the Sustainable Utilization of Deep Eutectic Solvents for Chitin Isolation from Diverse Sources.Polymers · 2024Review
- Benzenoid Aromatics from Renewable Resources.Chemical reviews · 2024Review
- Bacteriophage therapy reducesAntimicrobial agents and chemotherapy · 2024Article
- Synthesis and anti-inflammatory activities of two new N-acetyl glucosamine derivatives.Scientific reports · 2024Article
- High-level production of chitinase by multi-strategy combination optimization in Bacillus licheniformis.World journal of microbiology & biotechnology · 2024Article
- Metabolic analysis of the CAZy class glycosyltransferases in rhizospheric soil fungiome of the plant speciesSaudi journal of biological sciences · 2024Article
- Activity of a Recombinant Chitinase of thePolymers · 2024Article
- Article
- GlcNac produced by the gut microbiome enhances host influenza resistance by modulating NK cells.Gut microbes · 2023Article
- An overview of viral chitinases: General properties and biotechnological potential.Experimental biology and medicine (Maywood, N.J.) · 2023Review
51 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
N-Acetylglucosamine (GlcNAc) is a monosaccharide that usually polymerizes linearly through (1,4)-β-linkages. GlcNAc is the monomeric unit of the polymer chitin, the second most abundant carbohydrate after cellulose. In addition to serving as a component of this homogeneous polysaccharide, GlcNAc is also a basic component of hyaluronic acid and keratin sulfate on the cell surface. In this review, we discuss the industrial production of GlcNAc, using chitin as a substrate, by chemical, enzymatic and biotransformation methods. Also, newly developed methods to obtain GlcNAc using glucose as a substrate in genetically modified microorganisms are introduced. Moreover, GlcNAc has generated interest not only as an underutilized resource but also as a new functional material with high potential in various fields. Here we also take a closer look at the current applications of GlcNAc, and several new and cutting edge approaches in this fascinating area are thoroughly discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.